2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- PMID: 33215931
- DOI: 10.1161/CIR.0000000000000937
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Erratum in
-
Correction to: 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2020 Dec 22;142(25):e633. doi: 10.1161/CIR.0000000000000945. Epub 2020 Dec 21. Circulation. 2020. PMID: 33347333 No abstract available.
Keywords: AHA Scientific Statements; atrial fibrillation; cardiovascular magnetic resonance; diastolic dysfunction; echocardiography; exercise stress testing; family screening; genetics; guidelines; hypertrophic cardiomyopathy; implantable cardioverter defibrillator; left ventricular outflow tract obstruction; occupation; physical activity; pregnancy; rhythm monitoring; risk stratification; sarcomeric genes; septal alcohol ablation; septal reduction therapy; shared decision-making; sudden cardiac death; surgical myectomy; systolic dysfunction; ventricular arrhythmias.
Comment in
-
Diagnosis and Management of Hypertrophic Cardiomyopathy: Updated Guidelines From the ACC/AHA.Am Fam Physician. 2022 Feb 1;105(2):207-209. Am Fam Physician. 2022. PMID: 35166485 No abstract available.
Similar articles
-
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20. Circulation. 2020. PMID: 33215938 Review.
-
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.J Am Coll Cardiol. 2020 Dec 22;76(25):e159-e240. doi: 10.1016/j.jacc.2020.08.045. Epub 2020 Nov 20. J Am Coll Cardiol. 2020. PMID: 33229116 No abstract available.
-
2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.J Thorac Cardiovasc Surg. 2021 Jul;162(1):e23-e106. doi: 10.1016/j.jtcvs.2021.04.001. Epub 2021 Apr 27. J Thorac Cardiovasc Surg. 2021. PMID: 33926766 No abstract available.
-
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.Circulation. 2024 Jun 4;149(23):e1239-e1311. doi: 10.1161/CIR.0000000000001250. Epub 2024 May 8. Circulation. 2024. PMID: 38718139
-
Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline.Curr Cardiol Rep. 2016 Jul;18(8):70. doi: 10.1007/s11886-016-0751-8. Curr Cardiol Rep. 2016. PMID: 27294414 Review.
Cited by
-
Different mechanisms of mitral regurgitation in hypertrophic cardiomyopathy: A clinical case and literature review.Front Cardiovasc Med. 2022 Oct 28;9:1020054. doi: 10.3389/fcvm.2022.1020054. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36386345 Free PMC article. Review.
-
Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review.Am J Cardiovasc Drugs. 2024 Sep;24(5):591-602. doi: 10.1007/s40256-024-00667-z. Epub 2024 Jul 19. Am J Cardiovasc Drugs. 2024. PMID: 39030459 Free PMC article. Review.
-
Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.Wien Klin Wochenschr. 2024 Oct;136(Suppl 15):571-597. doi: 10.1007/s00508-024-02442-1. Epub 2024 Oct 1. Wien Klin Wochenschr. 2024. PMID: 39352517 Free PMC article.
-
Challenges and Applications of Genetic Testing in Dilated Cardiomyopathy: Genotype, Phenotype and Clinical Implications.Arq Bras Cardiol. 2023 Nov;120(10):e20230174. doi: 10.36660/abc.20230174. Arq Bras Cardiol. 2023. PMID: 38055534 Free PMC article. English, Portuguese.
-
Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review.J Clin Med. 2022 Jun 14;11(12):3405. doi: 10.3390/jcm11123405. J Clin Med. 2022. PMID: 35743475 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources